Quantitative metabolomics services for biomarker discovery and validation.
Specializing in ready to use metabolomics kits.
Your source for quantitative metabolomics technologies and bioinformatics.
Loader

Browsing Pathways

Filter by Pathway Type:


Showing 41 - 50 of 605359 pathways
SMPDB ID Pathway Name and Description Pathway Class Chemical Compounds Proteins

SMP0063728

Missing View Pathway

1

BioPAX SVG SBGN SBML PWML All files (.zip)
Signaling

SMP0145440

Pw147109 View Pathway

1,1-Dimethylbiguanide Drug Metabolism Pathway

Gadoversetamide is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Gadoversetamide passes through the liver and is then excreted from the body mainly through the kidney.
BioPAX SVG SBGN SBML PWML All files (.zip)
Metabolic

SMP0124655

Pw126139 View Pathway

1,2,3,7,8,9-Hexachlorodibenzofuran

BioPAX SVG SBGN SBML PWML All files (.zip)
Metabolic
  • 1,2,3,7,8,9-hexachlorodibenzo[b,d]furan-4-ol
  • 1,2,3,7,8,9-Hexachlorodibenzofuran
  • Heme

SMP0130706

Pw132374 View Pathway

1,2-Benzodiazepine Drug Metabolism

1,2-Benzodiazepine is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. 1,2-Benzodiazepine passes through the liver and is then excreted from the body mainly through the kidney.
BioPAX SVG SBGN SBML PWML All files (.zip)
Metabolic
  • 1,2-Benzodiazepine

SMP0144873

Pw146541 View Pathway

1,2-Benzodiazepine Drug Metabolism Action Pathway

BioPAX SVG SBGN SBML PWML All files (.zip)
Drug Action
  • 1,2-Benzodiazepine

SMP0145084

Pw146752 View Pathway

1,2-Distearoyllecithin Drug Metabolism Action Pathway

BioPAX SVG SBGN SBML PWML All files (.zip)
Drug Action
  • 1,2-Distearoyllecithin

SMP0145083

Pw146751 View Pathway

1,2-icosapentoyl-sn-glycero-3-phosphoserine Drug Metabolism Action Pathway

BioPAX SVG SBGN SBML PWML All files (.zip)
Drug Action
  • 1,2-icosapentoyl-sn-glycero-3-phosphoserine

SMP0127816

Pw129435 View Pathway

1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct Drug Metabolism

BioPAX SVG SBGN SBML PWML All files (.zip)
Metabolic

SMP0124716

Pw126201 View Pathway

1-Methylhistidine Metabolism

Methylhistidine is a modified amino acid that is produced in myocytes during the methylation of actin and myosin. It is also formed from the methylation of L-histidine, which takes the methyl group from S-adenosylmethionine and forms S-adenosylhomocysteine as a byproduct. After its formation in the myocytes, methylhistidine enters the blood stream and travels to the kidneys, where it is excreted in the urine. Methylhistidine is present in the blood and urine in higher concentrations after skeletal muscle protein breakdown, which can occur due to disease or injury. Because of this, it can be used to judge how much muscle breakdown is occurring. Methylhistidine levels are also affected by diet, and may differ between vegetarian diets and those containing meats.
BioPAX SVG SBGN SBML PWML All files (.zip)
Metabolic

SMP0124853

Pw126354 View Pathway

1-Methylhistidine synthesis via METTL9-catalyzed methylation

BioPAX SVG SBGN SBML PWML All files (.zip)
Metabolic
Showing 41 - 50 of 125271 pathways